Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US Capitol Capsule: Stem cell researchers breathe sigh of relief on vacated injunction

This article was originally published in Scrip

Executive Summary

Researchers last week cheered a 29 April ruling by a US appeals court that vacated an injunction imposed last August by a lower court on federal funding for research involving human embryonic stem cells (hESCs) – with the latest decision giving the Obama administration a big win in the case. The ruling also bodes well for companies involved in hESC research, although the 29 April decision has no impact on the clinical trials underway by the two US firms already given the US FDA's blessing to move forward.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC012762

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel